BeStock  
Stocks › Biotechnology › INVA

Innoviva INVA

US equityMarket cap rank #2978Biotechnology
$18.41 +$0.00 (0.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.41 0.00%
Open$18.41
Prev close$18.41
Day range$18.33 – $18.79
Volume1.15M
Market cap$1.31B
P/E (TTM)7.8
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings8.1x
CheapRich

Above its usual level · 61st percentile, 5-year average 10.3x

#409 of 2993 stocks by PE (1 = cheapest)

Price / book1.2x
CheapRich

Near the bottom of its 5-year range · 1st percentile, 5-year average 1.8x

#1765 of 5328 stocks by PB (1 = cheapest)

Price / sales3.1x
CheapRich

Around its usual level · 41st percentile, 5-year average 3.2x

#3220 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-28x0x29x58xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$20.40
Price vs. fair value-9.7%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyMedium
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.19 – 1.77 1% (cheaper than usual) #1765 of 5328 (1 = cheapest)
PE 8.10 9.09 10.31 61% (pricier than usual) #409 of 2993 (1 = cheapest)
PS 3.09 2.91 3.18 41% (cheaper than usual) #3220 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on INVA.

Sign in to join the discussion.

Scroll to Top